Want to join the conversation?
For 1Q16, $AMAT expects net sales to be down 2-9% sequentially and non-GAAP adjusted diluted EPS is expected to be in the range of $0.23-0.27. $AMAT's backlog remained essentially flat at $3.14Bil and included negative adjustments of $13MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?